1. Home
  2. CMI vs MRNA Comparison

CMI vs MRNA Comparison

Compare CMI & MRNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cummins Inc.

CMI

Cummins Inc.

N/A

Current Price

$529.45

Market Cap

71.1B

Sector

Industrials

ML Signal

N/A

Logo Moderna Inc.

MRNA

Moderna Inc.

N/A

Current Price

$206.90

Market Cap

61.6B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CMI
MRNA
Founded
1919
2010
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
71.1B
61.6B
IPO Year
1994
2018

Fundamental Metrics

Financial Performance
Metric
CMI
MRNA
Price
$529.45
$206.90
Analyst Decision
Buy
Hold
Analyst Count
22
23
Target Price
★ $708.66
$138.37
AVG Volume (30 Days)
989.8K
★ 16.2M
Earning Date
11-05-2026
11-06-2026
Dividend Yield
★ 1.69%
N/A
EPS Growth
N/A
★ 21.77
EPS
★ 11.44
N/A
Revenue
★ $33,670,000,000.00
$19,263,000,000.00
Revenue This Year
$11.87
$8.13
Revenue Next Year
$9.74
$16.26
P/E Ratio
$45.52
★ N/A
Revenue Growth
N/A
★ 4.29
52 Week Low
$418.77
$22.28
52 Week High
$737.76
$254.48

Technical Indicators

Market Signals
Indicator
CMI
MRNA
Relative Strength Index (RSI) 47.62 52.12
Support Level $527.76 $45.39
Resistance Level $540.49 N/A
Average True Range (ATR) 13.07 23.62
MACD 1.49 -5.05
Stochastic Oscillator 48.83 34.97

Price Performance

Historical Comparison
CMI
MRNA

About CMI Cummins Inc.

Cummins is a leading manufacturer of diesel and other engines used in heavy- and medium-duty commercial trucks, off-highway equipment, and locomotives, in addition to prime power and standby generators. The company also sells powertrain components, which include filtration products, transmissions, turbochargers, aftertreatment systems, and fuel systems. Sales are approximately 60% US and Canada and 40% rest of the world. Much of Cummins' foreign sales (China, India, and so forth) are through joint ventures. The company operates 650 distributors and over 19,000 dealer locations across 190 countries. Cummins' business model is unique as it competes with many of its heavy-duty truck manufacturer customers, which also make their own engines.

About MRNA Moderna Inc.

Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 25 mRNA development candidates in clinical studies as of March 2026. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.

Share on Social Networks: